Delivery Order SPE2DB24D2208-SPE2DB26FHGQL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Miebo 100% eye drops (3ml units) with a ceiling value of $6,484.51. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion on October 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $5,322.00 delivery order to AmerisourceBergen Drug Corp for Miebo 100% eye drop (3ml) on September 3, 2025, with completion by September 4, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Miebo 100% eye drop solution in 3ml units. This competitively awarded, non-set-aside contract carries a ceiling value of $7,183.12 and is structured as a firm fixed price delivery order with an ultimate completion date of August 20, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Miebo 100% eye drops (3 mL), with a ceiling value of $18,826.55. The contract utilizes a firm fixed-price delivery order structure with no set-aside designation, indicating competitive award based on AmerisourceBergen's demonstrated capability to meet federal procurement requirements. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Miebo 100% eye drop in 3ml quantities, with a ceiling value of $36,483.26. This firm fixed-price delivery order, which is not set-aside for any special contracting category, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and running through...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Miebo 100% eye drops in a 3 milliliter unit, with a ceiling value of $14,043.34 and an ultimate completion date of September 11, 2025. The contract was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Miebo 100% eye drop medication in 3 mL units. This competitively awarded, non-set-aside contract carries a ceiling value of $2,325.38 with a firm fixed price structure and an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The order represents...
- The Defense Logistics Agency awarded a delivery order valued at $13,997.08 to AmerisourceBergen Drug Corp for Miebo 100% eye drop solution (3ml) on August 26, 2025, with a completion date of August 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- AmerisourceBergen Drug Corp was awarded a $3,202.62 delivery order by the Defense Logistics Agency (DLA) on June 18, 2025, for the supply of Miebo 100% eye drop medication in 3ml quantities. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 20, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement under the company's existing contract...
- The Defense Logistics Agency awarded a delivery order valued at $8,490.73 to AmerisourceBergen Drug Corp on September 4, 2025, for MIEBO 100% eye drop solution in 3ml quantities. The contract is a firm fixed price delivery order with performance in Conshohocken, Pennsylvania, and an ultimate completion date of September 5, 2025. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete for federal pharmaceutical procurement...
- SPE2DB24D2208Indefinite Delivery Contract
- SPE2DB24D2208-SPE2DB26FHGQLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Miebo 100% eye drop in 3ml quantities, with a ceiling value of $1,683.30. This firm fixed price delivery order, which is expected to be completed by October 22, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The award was made through open competition with no set-aside designation, and performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the overarching vehicle enabling the company to supply pharmaceuticals and medical commodities to support military healthcare programs globally. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems across multiple therapeutic domains including specialty medications, vaccines, and medical devices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 10/21/25 |